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Approximately one in six married couples find themselves involuntarily infertile. This ratio
translates tobetween two and four million U.S. couples. Although numerous tests are available
for diagnosing infertility problems, 5-10 percent of all couples who seek medical treatment are
diagnosed with unexplained infertility. Several tests are presently available for diagnosing male
infertility; however, none of the present procedures test for activation of the sperm nucleus
following entry into the fertilized egg, a series of events critical for the entry of the zygote into
the developmental program. We have developed an in vitro human sperm activation assay, using
Xenopus laevis frog egg extract. When normal human sperm is permeabilized and then mixed
with frog egg extract, the sperm nuclei decondense, synthesize DNA, and recondense during a
three-hour time course. We have tested this assay's utility in diagnosing previously unexplained
infertility. We found that 20 percent of the male infertility patients produced sperm that
responded abnormallyin the assay (95 percent confidence interval, 4-48 percent; n = 15),while
sperm samples from 15 fertile males showed no abnormal responses (p = 0.112). These
preliminary results indicate that the human sperm activation assay may be a useful tool for
diagnosing some cases ofhuman infertility.
INTRODUCTION
During fertilization, the sperm nucleus is activated by the egg cytoplasm. The
activated sperm undergoes nuclear envelope breakdown and chromatin dispersion;
the male pronucleus is formed and surrounded by a new nuclear envelope; DNA is
synthesized in both the male and female pronuclei; and mitosis ensues, with nuclear
envelope breakdown and chromosome formation [1,2]. In order to identify the
factor(s) required for sperm activation, Lohka and Masui developed an in vitro frog
sperm activation assay [3]. They demonstrated that incubating demembranated
Xenopus laevis frog sperm in Ranapipiens frog egg extract induced sperm activation,
including chromatin decondensation, pronuclei formation, DNA synthesis, and
chromatin recondensation. These results were extended to the human system when
Gorden et al. [4] and Brown et al. [5] demonstrated that mixing permeabilized
human sperm with Xenopus laevis frog egg extract promoted the early events of
human sperm activation, including chromatin decondensation, pronuclei formation,
DNA synthesis, and chromatin recondensation. We now present results from the
first clinical application ofthe human sperm activation assay (HSAA), analyzing the
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sperm from 15 fertile males and 15 male unexplained infertility patients. An abstract
ofthis study has appeared elsewhere [6].
MATERIALS AND METHODS
Unexplained Infertility Patients
At the University ofTexas Medical Branch Infertility Clinic, a couple is diagnosed
as having unexplained infertility when the following conventional tests have been
completed without finding a cause for the couple's infertility: the female partnerwill
have undergone complete infertility evaluations, including post-coital tests (to rule
out sperm motility loss in cervical mucus), a timed endometrial biopsy (to exclude
luteal phase defect), a hysterosalpingogram (to establish tubal patency), and laparos-
copy (to rule out pelvic pathology); in the male partner, semen analysis should have
been normal on two occasionswith sperm concentrations greater than 20 million/ml,
total sperm numbers of 40 million or more, sperm motility greater than 60 percent,
and normal morphology in more than 60 percent of the sperm [7]. The inexplicably
infertile couples must also havebeen involuntarily infertile for over twoyears. In this
study, sperm was obtained from 15 unexplained infertility patients who have been
involuntarily infertile for more than five years (average of 7.3 years, range of five to
ten years). All of the semen samples from the unexplained infertility patients that
were analyzed in this study had normal sperm concentrations, total sperm counts,
motility, and morphology.
Human Sperm Preparation
All semen donors abstained from ejaculation for at least two days prior to the
collection ofthe semen samples that were obtained by masturbation.
Semen samples from 15 unexplained infertility patients were obtained at the time
ofthe regularly scheduled procedures at the infertility clinic (e.g., sperm penetration
assay, SPA; in vitro fertilization-embryo transfer, IVF-ET; and gamete intrafallopian
transfer, GIFT). The portion of the sample not used for these procedures (usually
discarded) was used forthe HSAA. These sampleswere kept in a4°Crefrigerator for
up to seven days forparallelweekly assays onsamples collected throughout theweek.
Semen samples from 15 fertile males were stored from one to seven days, mimicking
the storage conditions of the semen samples from the unexplained infertility pa-
tients. Fresh samples are not needed for the HSAA, as stored semen samples from a
fertile male were found to respond the same in the human sperm activation assays as
did sperm collected from the same fertile male on the day the assay was performed,
even after 4°C storage ofup to a month (data not shown).
On the day of the experiment, semen samples were incubated for 30 minutes at
37°C; each sample was then suspended in 10 ml of nuclear isolation medium (NIM,
200 mM sucrose, 2.4 mM MgCl2, 10 mMTris-HCl, and 5 mM maleic acid, pH 7.4). A
sperm countwas taken and an aliquot (containing 20million sperm) waspelleted in a
centrifuge for ten minutes at 400 g, then resuspended in 10 ml of NIM containing
0.05 percent lysolecithin and 1 ,ug/ml soybean trypsin inhibitor. The mixture was
kept at room temperature for five minutes and the sperm repelleted as before, then
washed, first in NIM with 3 percent BSA and then with NIM containing 0.4 percent
BSA, as described byLohka and Masui [3]. Spermwere finally suspended inXenopus
extract isolation medium (XEIM, 10 mM Tris-HCl, pH 7.5, 1.5 mM MgCl2, 100 mM
KCI, and 50 mM DTT) at a concentration of25,000 sperm/,ul and kept on ice for 45
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minutes before mixing with the frog egg extract. This XEIM (DTT) pre-treatment
was found to enhance the decondensation and DNA synthesis events (unpublished
observations), presumably by reducing the protamines that in mammalian sperm are
cross-linked by intermolecular disulfide bonds [8]. Xenopus laevis sperm contain
"intermediate" protamines [9] that are not cysteine-rich [10], so the frog egg extract
lacks the reducing factor(s) found in mammalian eggs that are required for reducing
the disulfide bridges of the human sperm; we must thus reduce the disulfide bonds
experimentally.
Xenopus laevis EggExtractIsolation
To promote oocyte maturation, ovulation, and egg laying, adult female Xenopus
laevis frogs were injected with 500 units of human chorionic gonadotropin in the
morning and evening of the day preceding the experiment. Mature eggs were
collected and dejellied with 2 percent cysteine-HCl, pH 7.6. The eggs were then
rinsed and incubated for one hour at room temperature in Barth's medium com-
posed of 88 mM NaCl, 1.0 mM KCl, 0.83 mM MgSO4, 0.34 mM Ca (NO3)2, 0.41 mM
CaCl2, 7.5 mM Tris-HCl, pH 7.6, 10 ,ug/ml penicillin, 10 Mg/ml streptomycin, and
2.4 mM Na(CO3)2. The eggs were washed three times in XEIM. Excess buffer was
removed and the eggs lysed by centrifugation at 10,000 g, 4°C, for 15 minutes in a
swinging bucket rotor. The resulting middle layer between the lipids and the egg
pellet was removed from the centrifuge tube, re-centrifuged, and the resulting
middle layer used as the stock extract solution. The extract was stored on ice until
used for the HSAA.
Human SpermActivationAssay (HSAA)
Permeabilized sperm from the normal controls and the infertility patients were
mixed separatelywith frog egg extract at a concentration of 150,000 sperm/150 ,ul of
extract. The permeabilized sperm were incubated at 19°C in extracts containing
3H-YTP at a concentration of 80 p,Ci/ml. Chromatin decondensation, DNA synthe-
sis, and chromatin recondensation were evaluated. Phase-contrast microscopy was
used to assess chromatin decondensation and recondensation. Aliquots (5 [lI) were
taken, placed on glass slides, and covered with glass cover slips at five and ten
minutes and at three hours following the addition of the sperm to the frog egg
extract. At the five- and ten-minute time points, the percentage of sperm that had
decondensed (Fig. 1B) was determined. Between 95-100 percent of the control
spermwere normally decondensed withinfive minutes. At the ten-minute timepoint,
between 95-100 percent normally have the appearance of the nucleus shown in Fig.
1B. At the three-hour time point, it was determined if the sperm nuclei had
recondensed their chromatin as maybe seen by the smaller nucleus shown in Fig. 1D
when compared to the nucleus shown in Fig. 1B. Recondensation was typically
observed in 95-100 percent ofthe control sperm. DNAsynthesis in the sperm nuclei
was assessed, using a 50 ,lI aliquot taken at the two-hour time point and diluted with
50 pl of phosphate-buffered saline. The sperm were then affixed to glass slides by
centrifugation, dried, and fixed for five minutes in Carnoy's fixative (three parts
ice-cold methanol to one part glacial acetic acid). These fixed cytopreps were then
dipped in 42°C Kodak nuclear track emulsion (NTB-2), stored at 4°C for twoweeks,
and then, following development, were Giemsa-stained through the emulsion. We
also made cytopreps at the 15-minute time point to observe chromatin smearing and
at the three-hour time point to see if the chromatin had recondensed to the level
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FIG. 1. Pictorial representation ofpermeabilized human sperm incubated in frog egg extract. Fig-
ures lA-lD are phase-contrast micrographs. Figures la-Id are bright-field micrographs of Giemsa-
stained nuclei. Figure lc is a Giemsa-stained autoradiograph. A,a: Time zero. B,b: 15-minute
incubation. C,c: Two-hour incubation. D,d: Three-hour incubation. Bar, 10 ,um.
shown in Fig. ld. The cytopreps were prepared and fixed as previously described,
followed by Giemsa staining without autoradiography. All microscopy was done
using a Leitz Orthoplan microscope. The micrographs in Figs. 1-4 were photo-
graphed at 800 X magnification, using a Zeiss Photomicroscope III. Two hundred
nuclei were scored for labeling and the results with control sperm (percentage ofthe
nuclei showing label above background) compared to thosewith the patients' sperm.
RESULTS
Normal Sperm (Control) Response in the HSAA
Apictorial representation ofa normal response ofpermeabilized human sperm to
the frog egg extract is shown in Fig. 1. The sperm nuclei shown in Figs. 1A-D and
la-d were photographed (800 x magnification) and printed at the same magnifica-
tion, with the bar representing 10 p,m. Phase-contrast microscopy was used when
photographing the nuclei shown in Figs. 1A-D, while Figs. la-d are bright-field
photographs of Giemsa-stained cytopreps, with the nuclei shown in Fig. lc being
Giemsa-stained autoradiographs. Permeabilized sperm without extract treatment
are shown in Figs. 1A and la. Following a five-minute incubation in the frog egg
extract, greater than 90 percent of the sperm are decondensing. After a 10- to
15-minute incubation in the extract, greater than 95 percent of the sperm have
completely decondensed nuclei. A typical completely decondensed sperm nucleus is
shown in Fig. 1B. We have observed that at the 15-minute time point, the sperm
nuclei do not remain intact during the cytocentrifugation procedure used when
32HUMAN SPERM ACTIVATION ASSAY
TABLE 1
Human Sperm Activation Assay Rating Scheme
% ofControl
<40 40-60 60-80 80-100
% Decondensing at five minutes - + ++ +++
% Decondensing at ten minutes - + ++ +++
% Synthesizing DNA at two hours - + + + ++ +
% Recondensing at three hours - + ++ +++
making cytopreps; the nuclei become smeared on to the glass slide (Fig. lb).
Following atwo-hour incubation in the frog egg extract, the sperm nuclei have begun
to recondense their chromatin. Notice the decrease in size of the sperm nucleus
shown in Fig. 1C as compared to the nucleus shown in Fig. 1B. The recondensed
sperm nuclei also withstand the cytocentrifugation procedure (note intact nuclei in
Fig. lc). The labeling of these nuclei indicates that they have undergone DNA
synthesis. Typically, >95 percent of the control nuclei are labeled following a
two-hour incubation in frog egg extract containing tritiated thymidine, while >95
percent are fully recondensed following a three-hour incubation. Examples of
recondensed nuclei are shown in Figs. 1D and ld.
Use oftheHSAA in theAnalysis ofthe Sperm Obtainedfrom FertileMales and
UnexplainedInfertilityPatients
Inthisstudy, spermsampleswere obtainedfrom 15 unexplained infertilitypatients
and 15 fertile males and prepared for use in the HSAA as described in Methods. In
eachHSAA, a sperm sample from afertile male (previously shown to produce sperm
that have a normal response in the HSAA) was also assayed as a parallel control. We
have developed a rating system (Table 1) comparing the HSAA responses of the
control sperm sample to the sperm samples obtained from 15 unexplained infertility
patients and 15 fertile males. The results ofthe pilot study are shown in Table 2. As
can quickly be ascertained bylooking at the data summarized in Table 2, three ofthe
sperm samples from the infertility patients responded abnormally in the HSAA,
whereas all sperm from fertile men responded normally in the assay.
CaseReports ofPatientsProducingSperm ThatRespondedAbnornally in the HSAA
Patient 4: Sperm from patient 4 sperm sample, although scored normal (60
percent) in the sperm penetration assay(SPA; [11-13]), had a diminished deconden-
sation response (50 percent decondensed afterfive minutes ofincubation in extract),
TABLE 2
Human Sperm Activation Assay Pilot Study Results
Decondensation Decondensation DNA Synthesis Recondensation
(5 minutes) (10 minutes) (2 hours) (3 hours)
Fertile males 1-15 +++ +++ +++ +++
Infertility patients 1-3, 5, 7-14 +++ +++ +++ +++
Infertility patient 4 + ++ +++ +++
Infertility patient 6 +++ +++ -+++
Infertility patient 15 + + + ?
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I I
FIG. 2. Bright-field photographs of
Giemsa-stained autoradiographsofsperm
nucleifollowingtwohoursofincubationin
frog egg extract. A. Fertile control
A labeled nuclei. B. Patient 6unlabeled
nuclei. Bar, 10pWm.
by which time normal human sperm were 95 percent decondensed. Even after a
ten-minute incubation, only 80 percent ofthe patient's sperm had decondensed. We
have repeated the HSAA for patient 4 using the excess sperm from an unsuccessful
GIFT attempt (four eggs transferred), finding 60 percent ofthe sperm decondensed
after five minutes of incubation in the extract, with 98 percent of the normal sperm
decondensing duringthe same incubation period. Following a ten-minute incubation
in the egg extract, 90 percent of the patient's sperm had decondensed, with 98
percent ofthe control spermbeing decondensed. When new samples ofthispatient's
sperm were obtained for use in the HSAA at 4, 11, and 13 months following the
initial analyses, this patient's sperm responded normally in the HSAA when com-
pared to the control sperm. During the time period where the patient's sperm was
responding normally in the HSAA, an IVF-ET attempt resulted in a successful
pregnancy; however, the pregnancy ended with a spontaneous miscarriage at six
weeks ofpregnancy. The sperm is from the male member ofa couple who have been
trying to conceive for ten years and at present, with the exception of our assay, the
couple has been found to be normal in every test performed.
Patient 6: Patient 6 has sperm that was seen to decondense and recondense in a
normal fashion. Only 27 percent of the sperm nuclei were found to be labeled
following autoradiography, however, while 100 percent of the control sperm nuclei
were found to be labeled. Autoradiographs of typical labeled control nuclei and
unlabeled patient nuclei are shown in Figs. 2A and 2B, respectively. This couple has
been trying to conceive for eight years. The sperm penetration assay has not been
performed for this patient.
Patient 15: Patient 15 has sperm that respondedvariably in the rate and extent of
decondensation and DNA synthesis. Only 50 percent ofthe sperm had decondensed
at both the five- and ten-minute time points with 45 percent showing partial
decondensation and 5 percent showing full decondensation. The cytopreps from the
15-minute time point are shown in Fig. 3. In Fig. 3A the typical smearing of the
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FIG. 3. Bright-field photographs of Giemsa-stained sperm nuclei following 15-minute incubations in
frog egg extract. A. Fertile control, decondensed and smeared nuclei. B. Patient 15, three nuclei
that are neither smeared nor decondensed by a decondensed smeared nucleus. Bar, 10 pLm.
sperm nuclei is shown, seen from control normal sperm in the HSAA. In Fig. 3B
sperm nuclei from patient 15 are shown, with three intact sperm nuclei and one
smeared nucleus. Sperm nuclei that are not decondensing maintain their nuclear
structure during cytocentrifugation, while decondensing sperm smear on the glass
slide. In Fig. 4 are shown the cytoprep-autoradiographs of sperm nuclei from a
FIG. 4. Bright-field micrographs of Giemsa-stained autoradiographs of sperm nuclei follow-
ing two hours of incubation in frog egg extract. A. Fertile control, decondensed labeled
sperm nucleus (96 percent). Figures B-F show examples of the variable decondensation
and labeling observed in patient 15 sperm nuclei. B. Nuclei neither decondensed, nor
labeled (41 percent). C. Nucleus decondensed and labeled (14 percent). D. Nucleus
decondensed and unlabeled (8 percent). E. Nucleus decondensed, smeared, and unlabeled
(7 percent). F. Nucleus decondensed, smeared, and labeled (30 percent). Bar, 10 pL.m
t..
-..M-
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control fertile male (Fig. 4A) and from patient 15 (Fig. 4B-F) that had been
incubated for two hours in egg extract containing tritiated thymidine. In the control
labeled nuclei, 96 percent were found to be labeled. Nuclei from patient 15 had
variable levels of decondensation, with 44 percent of the nuclei being labeled.
Forty-one percent of the nuclei were neither decondensed nor labeled (Fig. 4B), 14
percent were decondensed and labeled (Fig. 4C), 8 percent were decondensed and
unlabeled (Fig. 4D), 7 percentwere smeared andunlabeled (Fig. 4E), and 30percent
were smeared and labeled (Fig. 4F). This couple has tried to conceive for seven
years. Their sperm penetration assay score was zero. It is interesting to note that the
couple decided to take part in the sperm donor program available at the UTMB
clinic. Whenusingdonorsperm, thefirst attempt at artificial insemination resulted in
a pregnancy.
DISCUSSION
The results from this studydemonstrate that 20 percent ofthe males from couples
having unexplained infertility produce sperm that respond abnormally in the HSAA
(95 percent confidence interval of 4-48 percent; one-tailed Fisher exact test,
p = 0.112). Abnormal responses that were expected included lack of sperm chroma-
tin decondensation, diminished DNA replication, and/or abortive sperm chromatin
recondensation. Abnormal responses that were detected included: (1) a slow rate of
chromatin decondensation, (2) a low level of DNA synthesis, and (3) variability in
the rate and extent of decondensation and DNA synthesis. We did not find any
patients producing sperm that recondensed abnormally.
In the case ofpatient 4 (slow rate of chromatin decondensation), we determined
that the HSAA could be used to follow the patient's sperm quality as regards
fertilization potential when used in the IVF-ET procedure. While the sperm from
patient 4 was responding normally in the HSAA, the sperm fertilized an egg in vitro
and produced an embryo that was transferred into the patient's wife, resulting in a
successful pregnancy. This correlation demonstrates that the HSAA may have
potential for monitoring suitability of a particular semen sample forin vitro fertiliza-
tion. As far as we know, the three different semen samples (two showing abnormal
HSAA responses, one responding normally) were obtained from patient 4. It is not
clear why the patient would begin to produce sperm that respond normally in the
HSAA, following two abnormal responses. In the human male, spermatogenesis
takes 74days [14]. Duringthese 74days,various aspectsofspermatogenesis mightbe
sensitive to such environmental influences as temperature, tobacco and/or alcohol
use, or changes in the diet. As the environmental influences change, patients whose
spermatogenic environment changed might also undergo a change in semen quality.
We have, however, no evidence that such changes occurred in patient 4's environ-
ment.
Patient 15 (variability in the rate and extent of decondensation and DNA
synthesis) was producing abnormal sperm that did not respond properly in the
HSAA, or in the SPA. This finding led us to conclude that the problem with this
infertile couple was related to the male's sperm; the conclusion was substantiated by
the successful pregnancy that resulted following the first attempt at artificial insemi-
nation using donor sperm.
We do not believe that the abnormal sperm activation responses observed in this
study are a result ofvariability in the frog egg extracts used throughout the study. In
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each experiment, the frog egg extract was tested for sperm activation activity using
the sperm from a fertile male that hadbeen previously shown to respond normally in
the HSAA. No variability was seen in the sperm activation response of the control
spermwhen incubated in the different frog egg extracts.
We analyzedthe spermfrom 15 fertile males in orderto determinewhatfrequency
of males in a fertile population produce sperm that responds abnormally in the
sperm activation assay. All 15 samples from fertile males responded normally in the
assay. We therefore believe that the abnormal responses observed in the infertile
patients' samples suggest that thepatients are infertile as aresultofproducing sperm
deficient in fertilization capacity as regards the events that occur following the entry
ofthe sperm nucleus into the eggcytoplasm.
Several tests are presently available for diagnosing male infertility; these assay
sperm number, morphology, motility, and the ability to fuse with and then enter a
zona-free hamster egg, as occurs during the SPA [11-13]. None of the standard
procedures, with the exception of the SPA, test the activation of the sperm nucleus
following entry into the fertilized egg. The SPA score is determined by the percent-
age ofeggs that are penetratedbythe sperm, as determinedbycountingthe eggsthat
contain decondensed or activated sperm nuclei; however, one cannot use the SPA to
study the efficiency ofthe decondensation process. During the SPA, the hamster egg
routinelybecomes boundwith a large number ofsperm that do not enter the egg and
thus do not decondense. One cannot tell a non-decondensed sperm that is bound to
the eggfrom a sperm that has entered the egg and not decondensed as a result ofnot
responding to the egg activation signals. Interestingly, a zero SPA score may in some
cases reflect the sperm's inability to decondense, instead of its penetration capabili-
ties, as is presently assumed. As regards using the fertilized hamster eggs to follow
DNA synthesis and recondensation, the labor and expense that would be associated
with obtaining enough eggs to analyze one patientwould prohibit the use ofthe SPA
to study sperm activation as a routine clinical procedure. Conversely, the HSAA
allows the investigator routinecomparison ofhundredsofapatient's activated sperm
nuclei with those from a normal, fertile male and easily detects any abnormal
response, thus making this the assayofchoice for sperm activation.
Although the small sample size (n = 15) of this pilot study produced a wide 95
percent confidence interval, the sperm activation assay shows great promise in
diagnosing a major class of currently unexplained infertility. Clearly, we must now
use the HSAA to analyze a large number of sperm samples from unexplained
infertility patients in order to decrease the 95 percent confidence interval and to
determine more accurately the percentage of unexplained infertility patients who
canbe diagnosed bythe assayresults.
In conclusion, the results from this pilot study indicate that the HSAA may be a
useful tool fordiagnosing some cases ofmale infertility. With the presentprocedures
available fordiagnosinginfertilitypatients, it is estimated that 90 to 95 percent ofthe
patients who seek treatment at an infertility clinic can be diagnosed [15]. We have
developed, and now tested an HSAA in an attempt to diagnose some of the 5 to 10
percent of patients who are classified with unexplained infertility. Our assay allows
analysis of sperm activation events, including chromatin decondensation, pronuclei
formation, DNA synthesis, and chromatin recondensation. None of the other
available infertility tests assesses activation ofthe sperm nucleus following entry into
the fertilized egg, a series of events critical for the entry of the zygote into the
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developmental program. The HSAA will allow diagnosis of otherwise unexplained
infertility patients by determining that their infertility is a result oftheir sperm nuclei
not responding properly to the egg cytoplasm following fertilization. Couples having
unexplained infertility spend a large amount of money on current treatments. It is
estimated that as much as a billion dollars a year is spent by from 300,000 to one
million couples in pursuit of pregnancy [16]. As with patient 15, the HSAA can be
used to identify patients who cannot benefit from the available treatments of
infertility, thereby saving the associated expense and discomfort. Eventually, we
hope to develop methods to identify and perhaps ultimately to replace the defective
or missing components ofthe sperm that prevent normal sperm activation.
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